NCT01559883已完成不适用
Study on Thrombosis Therapy in German Cancer Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- LEO Pharma
- 入组人数
- 76
- 试验地点
- 1
- 主要终点
- treatment time on low molecular weight heparin
研究概览
简要总结
The study aims to document the flow of German patients with cancer and acute deep vein thrombosis from first visit to diagnosis and treatment, the applied diagnostic procedures, and therapy modalities.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patient with cancer and acute deep vein thrombosis and/or pulmonary embolism
排除标准
- •life expectancy less that 6 months
- •age less that 18 years
结局指标
主要结局
treatment time on low molecular weight heparin
时间窗: 1 year
次要结局
- patient pathways(1 year)
- risk factors for DVT(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study on Management Thrombosis in Greek Cancer PatientsThrombosisNCT03292107Hellenic Society of Medical Oncology500
已完成
不适用
A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)Treatment of Venous Thromboembolism in Cancer PatientsNCT05150938Bayer5,737
Unknown
不适用
Allo - Cancer - ThrombosisCancerVenous ThromboembolismNCT03563924Assistance Publique - Hôpitaux de Paris100
终止
3 期
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary EmbolismNeoplasmsVenous ThromboembolismNCT01164046University Medical Center Groningen56
已完成
3 期
A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)AnemiaVenous ThrombosisNCT00211146Johnson & Johnson Pharmaceutical Research & Development, L.L.C.680